文献速递神经肿瘤

垂体腺瘤手术中光学荧光剂的使用:该领域现状

Use of optical fluorescence agents during surgery for pituitary adenomas: current state of the field.
PubMed 文献 · J Neurooncol · 2018-12-06

本文按PRISMA指南系统综述垂体腺瘤(PA)手术中5-氨基乙酰丙酸(5-ALA)及其他光学荧光剂的应用,共纳入11项研究。结果显示5-ALA在两项研究中未显示有助于PA切除,ICG结果不一但倾向改善功能性PA的鉴别,OTL38对无功能性PA(尤其叶酸受体高表达者)有术中识别潜力,一项研究报道荧光素钠可产生临床有用的荧光。

要点

  • 5-ALA在两项研究中未显示有助于经标准内镜/显微途径的PA切除
  • ICG术中应用结果不一,但显示改善功能性PA鉴别的倾向
  • OTL38对无功能性PA的术中识别具潜力,尤其叶酸受体高表达肿瘤

核心结论

  • 作者结论认为,包括ICG和叶酸受体在内的部分光学荧光剂最有可能在区分PA与正常组织方面具有临床使用前景。

研究设计与样本

  • 按PRISMA指南开展系统文献综述,检索描述5-ALA及其他光学荧光剂用于PA荧光引导手术的研究,共11项研究符合纳入标准并接受综述。

主要发现

  • 两项研究中5-ALA未显示有助于经标准神经外科内镜/显微途径的PA切除。
  • 5-ALA光动力疗法在两个体外模型中评估,结果不一致。
  • ICG术中应用结论不一,但显示改善功能性PA鉴别的倾向。
  • OTL38显示对无功能性PA术中识别的潜力,尤其在叶酸受体高表达的肿瘤中。
  • 一项研究报道给予荧光素钠后可产生临床有用的荧光。

临床怎么用

  • 作者认为,包括ICG和叶酸受体在内的部分光学荧光剂最有可能在区分PA与正常组织方面具有临床使用前景。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Differentiation of normal pituitary from abnormal tumor tissue remains a surgical challenge despite improvements in optical visualization technology for pituitary adenoma (PA) surgery. During neurosurgical procedures for other tumor types, 5-aminolevulinic acid (5-ALA) has become a focus of investigation based on its high specificity in differentiating tumor tissue. However, the role of 5-ALA and other optical fluorescent agents in PA surgery remains less clear. OBJECTIVE: To perform a systematic review on the use of various optical fluorescent agents in PA surgery. METHOD: Using PRISMA guidelines, a systematic literature review to identify reports describing 5-ALA and other optical agents for fluorescence-guided surgery for PA was performed. Eleven research studies met inclusion criteria and were reviewed. RESULTS: In two studies, 5-ALA was not shown to be effective in aiding PA resection using standard neurosurgical endoscopic/microscopic approaches. 5-ALA photodynamic therapy was evaluated in two in-vitro models with inconsistent results. Intraoperative use of indocyanine green (ICG) concluded with varying results, but showed a tendency towards improved differentiation of functional PA. OTL38 showed potential for intraoperative identification of nonfunctioning PA, particularly in tumors with high folate receptor expression. One study reported clinically useful fluorescence following sodium fluorescein administration. CONCLUSION: We conclude that selected optical fluorescent agents, including ICG and folate receptors, are most likely to hold promise for clinical use in differentiating PA from normal tissue.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Chang SW, Donoho DA, Zada G, et al. Use of optical fluorescence agents during surgery for pituitary adenomas: current state of the field. J Neurooncol. 2018. PMID: 30523607. doi:10.1007/s11060-018-03062-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。